Abstract
Clinical flow cytometry is a reliable methodology for whole blood cell phenotyping for different applications. The BD FACSLyric™ system comprises a flow cytometer available in different optical configurations, BD FACSuite™ Clinical software, and optional BD FACS™ Universal Loader. BD FACSuite Clinical software used with BD™ FC Beads and BD CS&T Beads enable universal setup for performance QC, instrument control, data acquisition/storage, online/offline data analysis, and instrument standardization. BD Biosciences sponsored the clinical evaluation of the BD FACSLyric 10-color configuration at seven clinical sites using delinked and de-identified blood specimens from HIV-infected and uninfected subjects to enumerate T-, B-, and NK-lymphocytes with the BD Multitest™ reagents (BD Multitest IMK kit and BD Multitest 6-color TBNK). Samples were analyzed on the BD FACSLyric system with BD FACSuite Clinical software, and on the BD FACSCanto™ II system with BD FACSCanto clinical software and BD FACS 7-Color Setup beads. For equivalency between methods, data (n = 362) were analyzed with Deming regression for absolute count and percentage of lymphocytes. Results gave R2 ≥0.98, with slope values ≥0.96, and slope ranges between 0.90–1.05. The percent (%) bias values were <10% for T- and NK cells and <15% for B- cells. The between-site (n = 4) total precision was tested for 5 days (2 runs/day), and gave %coefficient of variation below 10% for absolute cell counts. The stability claims were confirmed (n = 186) for the two BD Multitest reagents. The reference intervals were re-established in male and female adults (n = 134). The analysis by gender showed statistically significant differences for CD3+ and CD4+ T-cell counts and %CD4. In summary, the BD FACSLyric and the BD FACSCanto II systems generated comparable measurements of T-, B-, and NK-cells using BD Multitest assays.
Highlights
Technical advances in flow cytometry have had a substantial impact in the understanding of the function and cell phenotyping of the T, B, and natural killer (NK) lymphocytes
The T, B, and NK lymphocyte sub-sets can be identified with selective cell markers and reagents using flow cytometry methods, which are extensively used in different types of immune deficiencies [5,6,7,8]
36 IMK and 39 TBNK samples were excluded from analysis because of instrument problems or not processed as per protocol
Summary
Technical advances in flow cytometry have had a substantial impact in the understanding of the function and cell phenotyping of the T-, B-, and natural killer (NK) lymphocytes. These cells are involved in cell-mediated immunity in the human immune deficiency virus (HIV) infection, immune and auto-immune responses in cancer, bacterial and viral infections, asthma, and rheumatoid arthritis [1,2,3,4,5]. Newer clinical analytical systems can simplify laboratory workflow, reduce the time or expertise required for analysis, and improve performance with high sensitivity and specificity, which enables improvement in sample testing throughput and cost reduction. Consistency in obtaining reproducible and accurate clinical results involves standardization of multiple factors across the laboratory testing continuum, including consistency in specimen collection and transportation, sample preparation, data acquisition, and reliable data analysis
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
